Scope 1, 2, and 3 greenhouse gas (GHG) emissions
The company has disclosed its targets for reducing fossil fuel-derived CO2 emissions in Japan by 46% by 2030 compared to 2013, and overseas by 24% compared to 2021. However, it is unclear whether these targets will result in a total reduction in Scope 1 and 2 emissions across all operations. It is important for the company to report progress on these Scope 1 and 2 targets, as well as align its targets with a 1.5-degree trajectory. By doing so, the company can reduce its greenhouse gas emissions in these scopes.
Additionally, the company has the opportunity to disclose a time-bound target for reducing its scope 3 greenhouse gas emissions. It is also crucial for the company to report progress on these scope 3 targets and align these targets with a 1.5-degree trajectory.
Animal welfare
The company has an opportunity to set animal welfare targets applicable to all species, geographies and products.
Antibiotic use and growth promoting substances
The company has an opportunity to disclose a policy on reducing the (prophylactic) use of antibiotics and/or growth promoting substances. Moreover, it can disclose targets to phase out the prophylactic use of antibiotics across all species, geographies and products and report progress against them.
Ecosystem conversion
The company has an opportunity to disclose activities and time-bound, group-wide targets to achieve conversion-free supply chains.
Sustainable fishing and aquaculture
The company demonstrates a clear dedication to sustainable fishing and aquaculture, but there is potential for improvement in providing quantitative evidence to showcase the progress made in these areas. Although the company has set a target for fishing and aquaculture and provides updates on its progress, it would be beneficial to also specify a timeframe for achieving this target.
Water withdrawal
The company has an opportunity to enhance its disclosures relating to water use and withdrawal.